Why choose St. Jude for your child’s histiocytosis treatment?

 

At St. Jude, your child will receive the most advanced treatment from an experienced team of specialists. Our experts are dedicated to giving children with histiocytic disorders the best treatment and quality of life.

  • St. Jude has the largest group of experts in the southeast U.S. specializing in the treatment of patients with histiocytic disorders.
  • St. Jude has been treating children with histiocytosis for nearly 50 years. Our treatment team has unique expertise with diagnosis, treatment and research in histiocytic disorders.
  • Your child will have access to a close-knit team that includes: 
    • doctors and nurses who treat histiocytic disorders,
    • surgeons,
    • experts in diagnostic imaging and nuclear medicine,
    • dietitians,
    • speech therapists,
    • rehabilitation specialists (physical and occupational therapists),
    • child life specialists,
    • psychologists,
    • Quality of Life team members,
    • experts who help manage and minimize the long-term or late effects of treatment,
    • researchers,
    • and many others.
St. Jude patient Jeziel
  • St. Jude is the coordinating center for the North American Consortium for Histiocytosis (NACHO). NACHO’s member hospitals work together to develop and test treatments for histiocytic disorders. St. Jude patients who qualify may take part in NACHO clinical trials.
  • The nurse-to-patient ratio at St. Jude is unmatched—averaging 1:3 in hematology and oncology, and 1:1 in the Intensive Care Unit.
  • St. Jude scientists are looking for ways to improve the outlook for patients whose organs are at risk and for those whose conditions do not improve after treatment. Scientists work closely with medical teams to turn discoveries from the lab into new treatment options for children.
  • Our group is actively involved with the global histiocytosis health care community. Our experts work closely with many other specialists across the world to help find better treatments for children with histiocytic disorders.
  • St. Jude has one of the world's largest stem cell transplant programs dedicated to caring for children, teens and young adults. Since the first stem cell transplant at St. Jude was performed in 1982, the Transplant Program has performed more than 2,900 transplants.
  • The Cancer Predisposition Program at St. Jude helps to evaluate and take care of children who are at increased genetic risk for cancer. This experienced team of doctors, nurses and genetic counselors works together with the histiocytosis treatment team to coordinate genetic counseling and testing for patients with histiocytosis and their families.

Refer a Histiocytosis Patient